Faculty of Pharmaceutical Science, Hokkaido University, Sapporo, Japan.
Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
FEBS J. 2020 Jan;287(1):145-159. doi: 10.1111/febs.14991. Epub 2019 Jul 22.
The measles virus (MV) is a major cause of childhood morbidity and mortality worldwide. We previously established a mouse monoclonal antibody, 2F4, which shows high neutralizing titers against eight different genotypes of MV. However, the molecular basis for the neutralizing activity of the 2F4 antibody remains incompletely understood. Here, we have evaluated the binding characteristics of a Fab fragment of the 2F4 antibody. Using the MV infectious assay, we demonstrated that 2F4 Fab inhibits viral entry via either of two cellular receptors, SLAM and Nectin4. Surface plasmon resonance (SPR) analysis of recombinant proteins indicated that 2F4 Fab interacts with MV hemagglutinin (MV-H) with a K value at the nm level. Furthermore, we designed a single-chain Fv fragment of 2F4 antibody as another potential biopharmaceutical to target measles. The stable 2F4 scFv was successfully prepared by the refolding method and shown to interact with MV-H at the μm level. Like 2F4 Fab, scFv inhibited receptor binding and viral entry. This indicates that 2F4 mAb uses the receptor-binding site and/or a neighboring region as an epitope with high affinity. These results provide insight into the neutralizing activity and potential therapeutic use of antibody fragments for MV infection.
麻疹病毒(MV)是全球导致儿童发病和死亡的主要原因。我们之前建立了一种鼠源单克隆抗体 2F4,该抗体对 8 种不同基因型的 MV 具有高中和效价。然而,2F4 抗体的中和活性的分子基础仍不完全清楚。在这里,我们评估了 2F4 抗体的 Fab 片段的结合特性。使用 MV 感染测定法,我们证明 2F4 Fab 通过两种细胞受体 SLAM 和 Nectin4 抑制病毒进入。重组蛋白的表面等离子体共振(SPR)分析表明,2F4 Fab 与 MV 血凝素(MV-H)相互作用的 K 值在纳米级。此外,我们设计了 2F4 抗体的单链 Fv 片段作为另一种针对麻疹的潜在生物制药。通过复性方法成功制备了稳定的 2F4 scFv,并表明其在 μm 级与 MV-H 相互作用。与 2F4 Fab 一样,scFv 抑制受体结合和病毒进入。这表明 2F4 mAb 以高亲和力使用受体结合位点和/或邻近区域作为表位。这些结果为 MV 感染的抗体片段的中和活性和潜在治疗用途提供了深入了解。